www.dicardiology.com Open in urlscan Pro
2606:4700::6812:be7  Public Scan

Form analysis
2 forms found in the DOM

POST /videos/video-examination-cardiac-covid-long-haulers

<form action="/videos/video-examination-cardiac-covid-long-haulers" method="post" id="custom-search-block-form" accept-charset="UTF-8">
  <div class="form-item js-form-item form-type-search js-form-type-search form-item-keys js-form-item-keys form-no-label form-group">
    <label for="edit-keys" class="control-label sr-only">Search this site</label>
    <input title="" class="custom_search-keys form-search form-control" data-drupal-selector="edit-keys" type="search" id="edit-keys" name="keys" value="" size="15" maxlength="128" data-toggle="tooltip"
      data-original-title="Enter the terms you wish to search for.">
  </div>
  <input autocomplete="off" data-drupal-selector="form-mdzzc-45z4ktvd2pnmfc0rxmqcqj9qietej6nqh30n0" type="hidden" name="form_build_id" value="form-mdzzC-45z4kTvD2pNMfc0rxmQcqj9qieTEJ6nqh30n0"><input
    data-drupal-selector="edit-custom-search-block-form" type="hidden" name="form_id" value="custom_search_block_form">
  <div data-drupal-selector="edit-actions" class="form-actions form-group js-form-wrapper form-wrapper" id="edit-actions"><button alt="Search" class="custom-search-button image-button js-form-submit form-submit btn-default btn"
      data-drupal-selector="edit-submit" type="image" id="edit-submit" src="/themes/custom/daic/images/search-icon.png" name=""></button></div>
</form>

POST /videos/video-examination-cardiac-covid-long-haulers

<form action="/videos/video-examination-cardiac-covid-long-haulers" method="post" id="custom-search-block-form--2" accept-charset="UTF-8">
  <div class="form-item js-form-item form-type-search js-form-type-search form-item-keys js-form-item-keys form-no-label form-group">
    <label for="edit-keys--2" class="control-label sr-only">Search this site</label>
    <input title="" class="custom_search-keys form-search form-control" data-drupal-selector="edit-keys" placeholder="Search" type="search" id="edit-keys--2" name="keys" value="" size="15" maxlength="128" data-toggle="tooltip"
      data-original-title="Enter the terms you wish to search for.">
  </div>
  <input autocomplete="off" data-drupal-selector="form-eulith2q8dpakg2i4phq9byhk9qzgv0pktwafrtzcbu" type="hidden" name="form_build_id" value="form-euLIth2Q8DpAKg2I4PHQ9bYhk9qZgv0PkTwafRTzcBU"><input
    data-drupal-selector="edit-custom-search-block-form-2" type="hidden" name="form_id" value="custom_search_block_form">
  <div data-drupal-selector="edit-actions" class="form-actions form-group js-form-wrapper form-wrapper" id="edit-actions--2"><button alt="" class="custom-search-button image-button js-form-submit form-submit btn-default btn"
      data-drupal-selector="edit-submit" type="image" id="edit-submit--2" src="/themes/custom/daic/images/search-icon.png" name=""></button></div>
</form>

Text Content

Skip to main content
X


Search this site




EYEBROW MENU

 * Magazine
   * About
   * Advertise
   * Archive
   * Contact Us
   * DAIC Awards
   * Subscribe to magazine
   * Subscribe to newsletters
 * Photo Galleries
 * Podcasts
 * Videos
 * Comparison Charts
 * Webinars
 * Blogs
 * Calendar
 * 360 Photos
 * Case Studies
 * Buyer's Guide

Search this site


Sign In
New User? Register Here



 * COVID-19
 * Imaging
    * Cardiac Ultrasound
    * Computed Tomography (CT)
    * Contrast Media
    * Magnetic Resonance Imaging (MRI)
    * Nuclear Imaging
    * Radiation Dose management

 * Cath Lab
    * Angiography systems
    * Balloon catheters
    * FFR Technologies
    * Hemostasis management
    * Hemodynamic Support
    * Hybrid OR
    * Intravascular imaging systems
    * Interventional radiology
    * Peripheral Artery Disease
    * Stents

 * EP Lab
    * Ablation systems
    * Atrial Fibrillation
    * Cardiac resynchronization therapy devices (CRT)
    * Implantable cardioverter defibrillators (ICD)
    * Leads, implantable devices
    * Pacemakers

 * Structural Heart
    * Congenital Heart
    * Heart Valve Technology
    * Hybrid OR
    * Left atrial appendage (LAA) occluders
    * Structural heart occluders/closure devices

 * Heart Failure
    * Stroke

 * Diagnostics
    * Blood Testing
    * ECG
    * Remote monitoring
    * Wearable Sensors

 * Pharma
 * Conference Coverage
    * ACC
    * AHA
    * AIMed
    * ASE
    * ASNC
    * EuroPCR
    * ESC
    * HIMSS
    * HRS
    * RSNA
    * SCAI
    * SCCT
    * TCT
    * VIVA

FacebookTwitterLinkedInPrintShare
Videos | Coronavirus (COVID-19) | January 25, 2022


VIDEO: EXAMINATION OF CARDIAC COVID LONG-HAULERS


Siddharth Singh discusses how to examine a long-COVID patient


Video Player is loading.
Play Video
Play
Mute

Current Time 0:00
/
Duration 5:31
Loaded: 2.97%


0:00
Stream Type LIVE
Seek to live, currently behind liveLIVE
Remaining Time -5:31
 
1x
Playback Rate

Chapters
 * Chapters

Descriptions
 * descriptions off, selected

Captions
 * captions settings, opens captions settings dialog
 * captions off, selected

Audio Track
 * en (Main), selected

Picture-in-PictureFullscreen

This is a modal window.



Beginning of dialog window. Escape will cancel and close the window.

TextColorWhiteBlackRedGreenBlueYellowMagentaCyanTransparencyOpaqueSemi-TransparentBackgroundColorBlackWhiteRedGreenBlueYellowMagentaCyanTransparencyOpaqueSemi-TransparentTransparentWindowColorBlackWhiteRedGreenBlueYellowMagentaCyanTransparencyTransparentSemi-TransparentOpaque
Font Size50%75%100%125%150%175%200%300%400%Text Edge
StyleNoneRaisedDepressedUniformDropshadowFont FamilyProportional
Sans-SerifMonospace Sans-SerifProportional SerifMonospace SerifCasualScriptSmall
Caps
Reset restore all settings to the default valuesDone
Close Modal Dialog

End of dialog window.

Close Modal Dialog

This is a modal window. This modal can be closed by pressing the Escape key or
activating the close button.



Siddharth Singh, M.D., director of the COVID-19 heart program, staff
cardiologist and echocardiographer, Cedars-Sinai Hospital, explains how they
work up cardiac patients in the Cedars-Sinai long-COVID clinic. He goes through
the list of exams  and labs they use in these patients.

Cardiac patients at the Cedar-Sinai long-COVID clinic are evaluated with a basic
physical exam, extensive family and medical history, an ECG, basic labs that
include troponin and BNP, D-dimer, A1C, lipid panel and a metabolic profile
since many patients have become much less active during the pandemic. Patients
with symptoms are evaluated with an echocardiogram, including global
longitudinal strain. If patients have abnormalities on the echo, or if there is
suspected pericarditis or myocarditis, the patient is referred for a cardiac MRI
with contrast. 

Watch more of this interview in the VIDEO: Cardiac Presentations in COVID
Long-haulers at Cedars-Sinai Hospital 


RELATED LONG-COVID CONTENT:

What We Know About Cardiac Long-COVID Two Years Into the Pandemic 

VIDEO: Long-term Cardiac Impacts of COVID-19 Two Years Into The Pandemic —
Interview with Aaron Baggish, M.D.

VIDEO: Long-COVID Presentations in Cardiology at Beaumont Hospital — Interview
with Justin Trivax, M.D.

VIDEO: Cardiac Presentations in COVID Long-haulers at Cedars-Sinai Hospital —
Interview with Siddharth Singh, M.D.

Find more COVID news and video

 

178 Views


RECENT VIDEOS VIEW ALL 634 ITEMS

Cardiac Imaging | February 01, 2022

VIDEO: The Role of FFR-CT Under the New Chest Pain Evaluation Guidelines

Interview with Campbell Rogers, M.D., chief medical officer of HeartFlow which
has developed a CT image-based fractional flow reserve (FFR-CT) algorithm. The
technology was recently included as a recommendation for front line chest pain
evaluations in the 2021 ACC/AHA chest pain evaluation guidelines.

The new guidelines gave high levels of evidence for the use of computed
tomography and FFR-CT cardiac imaging as front line imaging modalities for chest
pain evaluation.


RELATED CHEST PAIN IMAGING CONTENT:

First International Chest Pain Diagnosis Guidelines Released

VIDEO: Why the ASNC Did Not Endorse the 2021 Chest Pain Guidelines — Interview
with ASNC President Dennis Calnon, M.D.

 

Coronavirus (COVID-19) | February 01, 2022

VIDEO: FFR-CT May Aid Patient Assessments in the COVID Era

Campbell Rogers, M.D., chief medical officer of HeartFlow, explains how
hospitals are using CT image-based fractional flow reserve (FFR-CT) assessments
to speed throughput of patients in emergency rooms and reduce the need for
diagnostic angiograms during the COVID-19 pandemic.

 

Cardiac Imaging | February 01, 2022

VIDEO: Why the ASNC Did Not Endorse the 2021 Chest Pain Guidelines

American Society of Nuclear Cardiology (ASNC) President Dennis Calnon, M.D.,
MASNC, FASE, FSCCT, director of cardiac imaging for McConnell Heart Hospital at
Riverside Methodist Hospital, and director of nuclear imaging for Ohio Health
Heart and Vascular Physicians in Columbus, explains why the society did not
endorse the first-ever U.S. or international guideline for the evaluation and
diagnosis of patients with acute or stable chest pain.

Nuclear myocardial perfusion imaging (MPI) has been a gold-standard for
evaluation of coronary disease in patients for years, and it is included in the
new guidelines. However, computed tomography angiography (CTA) has seen immense
growth over the past decade and gained a prominent position in the guidelines as
a front line imaging modality. This is due to nearly all hospital emergency
rooms now having access to CT systems capable of performing immediate cardiac
exams. CT has been seen mainly as an anatomical imaging test, but it also can be
used for myocardial perfusion imaging using iodine contrast. While CT has had
limits with its ability to image through heavily calcified vessels or stents,
that is changing with new CT technologies now coming into service.

One new CT technology that is prominently included I the new chest pain
guidelines is CT fractional flow reserve (FFR-CT) imaging.  This uses a
computational fluid dynamics algorithm to analyze a patient's CTA. It sends back
a report and an interactive 3D reconstruction of all the coronary vessels that
shows a color coded drop in FFR ratios, which is a measure of blood flow. Past a
certain threshold, the reduced flow needs to be treated with revascularization.
Lower level blockages can be treated with drug therapies. FFR-CT is widely
expected in the coming years to become a gate keeper for invasive diagnostic
angiograms. The hope is it will eliminate the need for the majority of cath lab
angiogram exams and only send patients to the lab that need a stent or
angioplasty. 

However, the ASNC had major issues with FFR-CT being included in the chest pain
guidelines. Its board members argued there is need for more evidence and there
should have been more information contraindications for its use, which was
included on other imaging modalities in the guidelines. They also argued access
to the technology has been very limited. Calnon explains more detail in the
video on why this was a sticking point and caused the ASNC to not endorse the
guidelines.

Read more in the article — First International Chest Pain Diagnosis Guidelines
Released

Nuclear Imaging | February 01, 2022

VIDEO: Recent Advances in Cardiac Nuclear Imaging

American Society of Nuclear Cardiology (ASNC) President Dennis Calnon, M.D.,
MASNC, FASE, FSCCT, director of cardiac imaging for McConnell Heart Hospital at
Riverside Methodist Hospital, and director of nuclear imaging for Ohio Health
Heart and Vascular Physicians in Columbus, offers a concise overview of new
technologies that are enhancing cardiac nuclear imaging. He also explains some
of the new developments and uses for PET and SPECT imaging technology.

Find more nuclear imaging technology news

 


SPONSORED VIDEOS VIEW ALL 42 ITEMS

Cath Lab | January 13, 2022

VIDEO: Leveraging Analytics and Data Visualization in the Cath Lab

Advancements in analytics and data visualizations are helping to streamline
operations and improve productivity at cath labs across the country. Kootenai
Health in Coeur d'Alene Idaho has a single cath lab performing more than 2,000
cases per year. Diane Penkert, executive director of heart and vascular
services, discusses how the implementation of the Philips Performance Bridge
analytics platform has enabled them to better leverage cardiovascular procedure
data.

Information Technology | April 17, 2019

itnTV "Conversations": Creating an Interoperability Strategy

With Intellispace Enterprise Edition as the foundation, Philips Healthcare is
connecting facilities and service areas within enterprises, while developing
standards-based interoperability that preserves customers' investments and best
of breed systems. 

Hemodynamic Support Devices | March 06, 2019

VIDEO: Complex PCI Involving Prior CABG and Comorbidities

Perwaiz Meraj, M.D., FACC, FSCAI, director of interventional cardiology,
assistant professor, Donald and Barbara Zucker School of Medicine at
Hofstra/Northwell, Northwell Health System discusses the importance of
hemodynamic support to safely perform a percutaneous coronary intervention (PCI)
with prior coronary artery bypass graft (CABG) surgery and comorbidities. Learn
more at ProtectedPCI.com/DAIC.

In this video, Meraj discuss a complex coronary intervention of a 77-year-old
woman with stage 4 CKD, prior CABG, hypertension, hyperlipidemia, diabetes, who
presented with angina and NSTEMI with an ejection fraction of 40 percent. The
team at Northwell consulted with cardiac surgeons and the heart team, and
determined that this patient was too high risk for another bypass surgery. Read
more on this case.
 

Related Impella Video Content:

VIDEO: Analysis of Outcomes for 15,259 U.S. Patients with AMICS Supported with
the Impella Device — Interview with William O'Neill, M.D.

VIDEO: The Door-to-Unloading (DTU) STEMI Safety and Feasibility Trial —
Interview with Navin Kapur, M.D.

VIDEO: Cardiogenic Shock Case with Impella CP Support — Case study with Michael
Amponsah, M.D.,

 

 

Heart Failure | February 13, 2019

VIDEO: Analysis of Outcomes for 15,259 U.S. Patients with AMICS Supported with
the Impella Device

William O'Neill, M.D., highlights best practice protocols based on Impella
Quality database and real-world evidence showing improved outcomes in
cardiogenic shock. Learn more at ProtectedPCI.com/DAIC

 

Related Impella Video Content:

VIDEO: Complex PCI Involving Prior CABG and Comorbidities — Interview with
Perwaiz Meraj, M.D.

VIDEO: The Door-to-Unloading (DTU) STEMI Safety and Feasibility Trial —
Interview with Navin Kapur, M.D.

VIDEO: Cardiogenic Shock Case with Impella CP Support — Case study with Michael
Amponsah, M.D.,

 


CONFERENCE COVERAGE VIEW ALL 455 ITEMS

Cardiac Imaging | February 01, 2022

VIDEO: Why the ASNC Did Not Endorse the 2021 Chest Pain Guidelines

American Society of Nuclear Cardiology (ASNC) President Dennis Calnon, M.D.,
MASNC, FASE, FSCCT, director of cardiac imaging for McConnell Heart Hospital at
Riverside Methodist Hospital, and director of nuclear imaging for Ohio Health
Heart and Vascular Physicians in Columbus, explains why the society did not
endorse the first-ever U.S. or international guideline for the evaluation and
diagnosis of patients with acute or stable chest pain.

Nuclear myocardial perfusion imaging (MPI) has been a gold-standard for
evaluation of coronary disease in patients for years, and it is included in the
new guidelines. However, computed tomography angiography (CTA) has seen immense
growth over the past decade and gained a prominent position in the guidelines as
a front line imaging modality. This is due to nearly all hospital emergency
rooms now having access to CT systems capable of performing immediate cardiac
exams. CT has been seen mainly as an anatomical imaging test, but it also can be
used for myocardial perfusion imaging using iodine contrast. While CT has had
limits with its ability to image through heavily calcified vessels or stents,
that is changing with new CT technologies now coming into service.

One new CT technology that is prominently included I the new chest pain
guidelines is CT fractional flow reserve (FFR-CT) imaging.  This uses a
computational fluid dynamics algorithm to analyze a patient's CTA. It sends back
a report and an interactive 3D reconstruction of all the coronary vessels that
shows a color coded drop in FFR ratios, which is a measure of blood flow. Past a
certain threshold, the reduced flow needs to be treated with revascularization.
Lower level blockages can be treated with drug therapies. FFR-CT is widely
expected in the coming years to become a gate keeper for invasive diagnostic
angiograms. The hope is it will eliminate the need for the majority of cath lab
angiogram exams and only send patients to the lab that need a stent or
angioplasty. 

However, the ASNC had major issues with FFR-CT being included in the chest pain
guidelines. Its board members argued there is need for more evidence and there
should have been more information contraindications for its use, which was
included on other imaging modalities in the guidelines. They also argued access
to the technology has been very limited. Calnon explains more detail in the
video on why this was a sticking point and caused the ASNC to not endorse the
guidelines.

Read more in the article — First International Chest Pain Diagnosis Guidelines
Released

Nuclear Imaging | February 01, 2022

VIDEO: Recent Advances in Cardiac Nuclear Imaging

American Society of Nuclear Cardiology (ASNC) President Dennis Calnon, M.D.,
MASNC, FASE, FSCCT, director of cardiac imaging for McConnell Heart Hospital at
Riverside Methodist Hospital, and director of nuclear imaging for Ohio Health
Heart and Vascular Physicians in Columbus, offers a concise overview of new
technologies that are enhancing cardiac nuclear imaging. He also explains some
of the new developments and uses for PET and SPECT imaging technology.

Find more nuclear imaging technology news

 

Artificial Intelligence | January 13, 2022

VIDEO: Examples of Artificial Intelligence PE Response Team Apps

Here are two examples of artificial intelligence (AI) driven pulmonary embolism
(PE) response team apps featured by vendors Aidoc and Viz.AI at the 2021
Radiological Society of North America (RSNA) 2021 meeting.

The AI scans computed tomography (CT) image datasets as they came off the
imaging system and looked for evidence of PE. If detected by the algorithm, it
immediately sends an alert to the stroke care team members via smartphone
messaging. This is done before the images are even loaded into the PACS. The
radiologist on the team can use a link on the app to open the CT dataset and has
basic tools for scrolling, windowing and leveling to determine if there is a PE
and the severity. The team can then use the app to send messages, access patient
information, imaging and reports. This enabled them all to be on the same
page and can communicate quickly via mobile devices, rather than being required
to use dedicated workstations in the hospital. 

Both vendors showed similar apps for stroke at RSNA 2019. That idea for rapid
alerts, diagnosis and communications for acute care teams has now expanded to PE
and also for aortic dissection and abdominal aortic aneurysms (AAA). AI.Viz and
Aidoc are looking at expanding this type of technology for other acute care team
rolls, including heart failure response. 

Read more about this technology in the article AI Can Facilitate Automated
Activation of Pulmonary Embolism Response Teams.

Find more AI news

Find more RSNA news and video

 

 

Coronavirus (COVID-19) | December 14, 2021

VIDEO: Study Reviews Severity of COVID-19 Heart Inflammation in College Athletes

Jean Jeudy, M.D., professor of radiology and vice chair of informatics at the
University of Maryland School of Medicine, presented a late-breaking study at
the 2021 Radiological Society of North America (RSNA) meeting on COVID-19 linked
myocarditis in college athletes. 

A small but significant percentage of college
athletes with COVID-19 develop myocarditis, a potentially dangerous inflammation
of the heart muscle, that can only be seen on cardiac MRI, according to the
study Jeudy presented. Myocarditis, which typically occurs as a result of a
bacterial or viral infection, can affect the heart’s rhythm and ability to pump
and often leaves behind lasting damage in the form of scarring to the heart
muscle. It has been linked to as many as 20% of sudden deaths in young athletes.
The COVID-19 pandemic raised concerns over an increased incidence of the
condition in student-athletes.

For the new study, clinicians at schools in the highly competitive Big Ten
athletic conference collaborated to collect data on the frequency of myocarditis
in student-athletes recovering from COVID-19 infection. Conference officials had
required all athletes who had COVID-19 to get a series of cardiac tests before
returning to play, providing a unique opportunity for researchers to collect
data on the athletes’ cardiac status.

Jeudy serves as the cardiac MRI core leader for the Big Ten Cardiac Registry.
This registry oversaw the collection of all the data from the individual schools
of the Big Ten conference. He reviewed the results of 1,597 cardiac MRI exams
collected at the 13 participating schools. 

Thirty-seven of the athletes, or 2.3%, were diagnosed with COVID-19 myocarditis,
a percentage on par with the incidence of myocarditis in the general population.
However, an alarmingly high proportion of the myocarditis cases were found in
athletes with no clinical symptoms. Twenty of the patients with COVID-19
myocarditis (54%) had neither cardiac symptoms nor cardiac testing
abnormalities. Only cardiac MRI identified the problem.

Read more details in the article COVID-19 Linked to Heart Inflammation in
College Athletes.


RELATED COVID-19 IMAGING AND MYOCARDITIS CONTENT:

Overview of Myocarditis Cases Caused by the COVID-19 Vaccine

COVID-19 Linked to Heart Inflammation in College Athletes — RSNA 2021
late-breaker

VIDEO: Cardiac MRI Assessment of Non-ischemic Myocardial Inflammation Caused by
COVID-19 Vaccinations — Interview with Kate Hanneman, M.D.

Cardiac MRI of Myocarditis After COVID-19 Vaccination in Adolescents

Large International Study Reveals Spectrum of COVID-19 Brain Complications -
RSNA 2021 late-breaker

COVID-19 During Pregnancy Doesn’t Harm Baby’s Brain

VIDEO: Large Radiology Study Reveals Spectrum of COVID-19 Brain Complications —
Interview with Scott Faro, M.D.

FDA Adds Myocarditis Warning to COVID mRNA Vaccine Clinician Fact Sheets

Small Number of Patients Have Myocarditis-like Illness After COVID-19
Vaccination


CATH LAB VIEW ALL 316 ITEMS

Cardiac Imaging | February 01, 2022

VIDEO: Why the ASNC Did Not Endorse the 2021 Chest Pain Guidelines

American Society of Nuclear Cardiology (ASNC) President Dennis Calnon, M.D.,
MASNC, FASE, FSCCT, director of cardiac imaging for McConnell Heart Hospital at
Riverside Methodist Hospital, and director of nuclear imaging for Ohio Health
Heart and Vascular Physicians in Columbus, explains why the society did not
endorse the first-ever U.S. or international guideline for the evaluation and
diagnosis of patients with acute or stable chest pain.

Nuclear myocardial perfusion imaging (MPI) has been a gold-standard for
evaluation of coronary disease in patients for years, and it is included in the
new guidelines. However, computed tomography angiography (CTA) has seen immense
growth over the past decade and gained a prominent position in the guidelines as
a front line imaging modality. This is due to nearly all hospital emergency
rooms now having access to CT systems capable of performing immediate cardiac
exams. CT has been seen mainly as an anatomical imaging test, but it also can be
used for myocardial perfusion imaging using iodine contrast. While CT has had
limits with its ability to image through heavily calcified vessels or stents,
that is changing with new CT technologies now coming into service.

One new CT technology that is prominently included I the new chest pain
guidelines is CT fractional flow reserve (FFR-CT) imaging.  This uses a
computational fluid dynamics algorithm to analyze a patient's CTA. It sends back
a report and an interactive 3D reconstruction of all the coronary vessels that
shows a color coded drop in FFR ratios, which is a measure of blood flow. Past a
certain threshold, the reduced flow needs to be treated with revascularization.
Lower level blockages can be treated with drug therapies. FFR-CT is widely
expected in the coming years to become a gate keeper for invasive diagnostic
angiograms. The hope is it will eliminate the need for the majority of cath lab
angiogram exams and only send patients to the lab that need a stent or
angioplasty. 

However, the ASNC had major issues with FFR-CT being included in the chest pain
guidelines. Its board members argued there is need for more evidence and there
should have been more information contraindications for its use, which was
included on other imaging modalities in the guidelines. They also argued access
to the technology has been very limited. Calnon explains more detail in the
video on why this was a sticking point and caused the ASNC to not endorse the
guidelines.

Read more in the article — First International Chest Pain Diagnosis Guidelines
Released

Nuclear Imaging | February 01, 2022

VIDEO: Recent Advances in Cardiac Nuclear Imaging

American Society of Nuclear Cardiology (ASNC) President Dennis Calnon, M.D.,
MASNC, FASE, FSCCT, director of cardiac imaging for McConnell Heart Hospital at
Riverside Methodist Hospital, and director of nuclear imaging for Ohio Health
Heart and Vascular Physicians in Columbus, offers a concise overview of new
technologies that are enhancing cardiac nuclear imaging. He also explains some
of the new developments and uses for PET and SPECT imaging technology.

Find more nuclear imaging technology news

 

Artificial Intelligence | January 13, 2022

VIDEO: Examples of Artificial Intelligence PE Response Team Apps

Here are two examples of artificial intelligence (AI) driven pulmonary embolism
(PE) response team apps featured by vendors Aidoc and Viz.AI at the 2021
Radiological Society of North America (RSNA) 2021 meeting.

The AI scans computed tomography (CT) image datasets as they came off the
imaging system and looked for evidence of PE. If detected by the algorithm, it
immediately sends an alert to the stroke care team members via smartphone
messaging. This is done before the images are even loaded into the PACS. The
radiologist on the team can use a link on the app to open the CT dataset and has
basic tools for scrolling, windowing and leveling to determine if there is a PE
and the severity. The team can then use the app to send messages, access patient
information, imaging and reports. This enabled them all to be on the same
page and can communicate quickly via mobile devices, rather than being required
to use dedicated workstations in the hospital. 

Both vendors showed similar apps for stroke at RSNA 2019. That idea for rapid
alerts, diagnosis and communications for acute care teams has now expanded to PE
and also for aortic dissection and abdominal aortic aneurysms (AAA). AI.Viz and
Aidoc are looking at expanding this type of technology for other acute care team
rolls, including heart failure response. 

Read more about this technology in the article AI Can Facilitate Automated
Activation of Pulmonary Embolism Response Teams.

Find more AI news

Find more RSNA news and video

 

 

Coronavirus (COVID-19) | December 14, 2021

VIDEO: Study Reviews Severity of COVID-19 Heart Inflammation in College Athletes

Jean Jeudy, M.D., professor of radiology and vice chair of informatics at the
University of Maryland School of Medicine, presented a late-breaking study at
the 2021 Radiological Society of North America (RSNA) meeting on COVID-19 linked
myocarditis in college athletes. 

A small but significant percentage of college
athletes with COVID-19 develop myocarditis, a potentially dangerous inflammation
of the heart muscle, that can only be seen on cardiac MRI, according to the
study Jeudy presented. Myocarditis, which typically occurs as a result of a
bacterial or viral infection, can affect the heart’s rhythm and ability to pump
and often leaves behind lasting damage in the form of scarring to the heart
muscle. It has been linked to as many as 20% of sudden deaths in young athletes.
The COVID-19 pandemic raised concerns over an increased incidence of the
condition in student-athletes.

For the new study, clinicians at schools in the highly competitive Big Ten
athletic conference collaborated to collect data on the frequency of myocarditis
in student-athletes recovering from COVID-19 infection. Conference officials had
required all athletes who had COVID-19 to get a series of cardiac tests before
returning to play, providing a unique opportunity for researchers to collect
data on the athletes’ cardiac status.

Jeudy serves as the cardiac MRI core leader for the Big Ten Cardiac Registry.
This registry oversaw the collection of all the data from the individual schools
of the Big Ten conference. He reviewed the results of 1,597 cardiac MRI exams
collected at the 13 participating schools. 

Thirty-seven of the athletes, or 2.3%, were diagnosed with COVID-19 myocarditis,
a percentage on par with the incidence of myocarditis in the general population.
However, an alarmingly high proportion of the myocarditis cases were found in
athletes with no clinical symptoms. Twenty of the patients with COVID-19
myocarditis (54%) had neither cardiac symptoms nor cardiac testing
abnormalities. Only cardiac MRI identified the problem.

Read more details in the article COVID-19 Linked to Heart Inflammation in
College Athletes.


RELATED COVID-19 IMAGING AND MYOCARDITIS CONTENT:

Overview of Myocarditis Cases Caused by the COVID-19 Vaccine

COVID-19 Linked to Heart Inflammation in College Athletes — RSNA 2021
late-breaker

VIDEO: Cardiac MRI Assessment of Non-ischemic Myocardial Inflammation Caused by
COVID-19 Vaccinations — Interview with Kate Hanneman, M.D.

Cardiac MRI of Myocarditis After COVID-19 Vaccination in Adolescents

Large International Study Reveals Spectrum of COVID-19 Brain Complications -
RSNA 2021 late-breaker

COVID-19 During Pregnancy Doesn’t Harm Baby’s Brain

VIDEO: Large Radiology Study Reveals Spectrum of COVID-19 Brain Complications —
Interview with Scott Faro, M.D.

FDA Adds Myocarditis Warning to COVID mRNA Vaccine Clinician Fact Sheets

Small Number of Patients Have Myocarditis-like Illness After COVID-19
Vaccination


CARDIAC IMAGING VIEW ALL 282 ITEMS

Cardiac Imaging | February 01, 2022

VIDEO: Why the ASNC Did Not Endorse the 2021 Chest Pain Guidelines

American Society of Nuclear Cardiology (ASNC) President Dennis Calnon, M.D.,
MASNC, FASE, FSCCT, director of cardiac imaging for McConnell Heart Hospital at
Riverside Methodist Hospital, and director of nuclear imaging for Ohio Health
Heart and Vascular Physicians in Columbus, explains why the society did not
endorse the first-ever U.S. or international guideline for the evaluation and
diagnosis of patients with acute or stable chest pain.

Nuclear myocardial perfusion imaging (MPI) has been a gold-standard for
evaluation of coronary disease in patients for years, and it is included in the
new guidelines. However, computed tomography angiography (CTA) has seen immense
growth over the past decade and gained a prominent position in the guidelines as
a front line imaging modality. This is due to nearly all hospital emergency
rooms now having access to CT systems capable of performing immediate cardiac
exams. CT has been seen mainly as an anatomical imaging test, but it also can be
used for myocardial perfusion imaging using iodine contrast. While CT has had
limits with its ability to image through heavily calcified vessels or stents,
that is changing with new CT technologies now coming into service.

One new CT technology that is prominently included I the new chest pain
guidelines is CT fractional flow reserve (FFR-CT) imaging.  This uses a
computational fluid dynamics algorithm to analyze a patient's CTA. It sends back
a report and an interactive 3D reconstruction of all the coronary vessels that
shows a color coded drop in FFR ratios, which is a measure of blood flow. Past a
certain threshold, the reduced flow needs to be treated with revascularization.
Lower level blockages can be treated with drug therapies. FFR-CT is widely
expected in the coming years to become a gate keeper for invasive diagnostic
angiograms. The hope is it will eliminate the need for the majority of cath lab
angiogram exams and only send patients to the lab that need a stent or
angioplasty. 

However, the ASNC had major issues with FFR-CT being included in the chest pain
guidelines. Its board members argued there is need for more evidence and there
should have been more information contraindications for its use, which was
included on other imaging modalities in the guidelines. They also argued access
to the technology has been very limited. Calnon explains more detail in the
video on why this was a sticking point and caused the ASNC to not endorse the
guidelines.

Read more in the article — First International Chest Pain Diagnosis Guidelines
Released

Nuclear Imaging | February 01, 2022

VIDEO: Recent Advances in Cardiac Nuclear Imaging

American Society of Nuclear Cardiology (ASNC) President Dennis Calnon, M.D.,
MASNC, FASE, FSCCT, director of cardiac imaging for McConnell Heart Hospital at
Riverside Methodist Hospital, and director of nuclear imaging for Ohio Health
Heart and Vascular Physicians in Columbus, offers a concise overview of new
technologies that are enhancing cardiac nuclear imaging. He also explains some
of the new developments and uses for PET and SPECT imaging technology.

Find more nuclear imaging technology news

 

Artificial Intelligence | January 13, 2022

VIDEO: Examples of Artificial Intelligence PE Response Team Apps

Here are two examples of artificial intelligence (AI) driven pulmonary embolism
(PE) response team apps featured by vendors Aidoc and Viz.AI at the 2021
Radiological Society of North America (RSNA) 2021 meeting.

The AI scans computed tomography (CT) image datasets as they came off the
imaging system and looked for evidence of PE. If detected by the algorithm, it
immediately sends an alert to the stroke care team members via smartphone
messaging. This is done before the images are even loaded into the PACS. The
radiologist on the team can use a link on the app to open the CT dataset and has
basic tools for scrolling, windowing and leveling to determine if there is a PE
and the severity. The team can then use the app to send messages, access patient
information, imaging and reports. This enabled them all to be on the same
page and can communicate quickly via mobile devices, rather than being required
to use dedicated workstations in the hospital. 

Both vendors showed similar apps for stroke at RSNA 2019. That idea for rapid
alerts, diagnosis and communications for acute care teams has now expanded to PE
and also for aortic dissection and abdominal aortic aneurysms (AAA). AI.Viz and
Aidoc are looking at expanding this type of technology for other acute care team
rolls, including heart failure response. 

Read more about this technology in the article AI Can Facilitate Automated
Activation of Pulmonary Embolism Response Teams.

Find more AI news

Find more RSNA news and video

 

 

Coronavirus (COVID-19) | December 14, 2021

VIDEO: Study Reviews Severity of COVID-19 Heart Inflammation in College Athletes

Jean Jeudy, M.D., professor of radiology and vice chair of informatics at the
University of Maryland School of Medicine, presented a late-breaking study at
the 2021 Radiological Society of North America (RSNA) meeting on COVID-19 linked
myocarditis in college athletes. 

A small but significant percentage of college
athletes with COVID-19 develop myocarditis, a potentially dangerous inflammation
of the heart muscle, that can only be seen on cardiac MRI, according to the
study Jeudy presented. Myocarditis, which typically occurs as a result of a
bacterial or viral infection, can affect the heart’s rhythm and ability to pump
and often leaves behind lasting damage in the form of scarring to the heart
muscle. It has been linked to as many as 20% of sudden deaths in young athletes.
The COVID-19 pandemic raised concerns over an increased incidence of the
condition in student-athletes.

For the new study, clinicians at schools in the highly competitive Big Ten
athletic conference collaborated to collect data on the frequency of myocarditis
in student-athletes recovering from COVID-19 infection. Conference officials had
required all athletes who had COVID-19 to get a series of cardiac tests before
returning to play, providing a unique opportunity for researchers to collect
data on the athletes’ cardiac status.

Jeudy serves as the cardiac MRI core leader for the Big Ten Cardiac Registry.
This registry oversaw the collection of all the data from the individual schools
of the Big Ten conference. He reviewed the results of 1,597 cardiac MRI exams
collected at the 13 participating schools. 

Thirty-seven of the athletes, or 2.3%, were diagnosed with COVID-19 myocarditis,
a percentage on par with the incidence of myocarditis in the general population.
However, an alarmingly high proportion of the myocarditis cases were found in
athletes with no clinical symptoms. Twenty of the patients with COVID-19
myocarditis (54%) had neither cardiac symptoms nor cardiac testing
abnormalities. Only cardiac MRI identified the problem.

Read more details in the article COVID-19 Linked to Heart Inflammation in
College Athletes.


RELATED COVID-19 IMAGING AND MYOCARDITIS CONTENT:

Overview of Myocarditis Cases Caused by the COVID-19 Vaccine

COVID-19 Linked to Heart Inflammation in College Athletes — RSNA 2021
late-breaker

VIDEO: Cardiac MRI Assessment of Non-ischemic Myocardial Inflammation Caused by
COVID-19 Vaccinations — Interview with Kate Hanneman, M.D.

Cardiac MRI of Myocarditis After COVID-19 Vaccination in Adolescents

Large International Study Reveals Spectrum of COVID-19 Brain Complications -
RSNA 2021 late-breaker

COVID-19 During Pregnancy Doesn’t Harm Baby’s Brain

VIDEO: Large Radiology Study Reveals Spectrum of COVID-19 Brain Complications —
Interview with Scott Faro, M.D.

FDA Adds Myocarditis Warning to COVID mRNA Vaccine Clinician Fact Sheets

Small Number of Patients Have Myocarditis-like Illness After COVID-19
Vaccination


CARDIAC DIAGNOSTICS VIEW ALL 78 ITEMS

Cardiac Imaging | February 01, 2022

VIDEO: Why the ASNC Did Not Endorse the 2021 Chest Pain Guidelines

American Society of Nuclear Cardiology (ASNC) President Dennis Calnon, M.D.,
MASNC, FASE, FSCCT, director of cardiac imaging for McConnell Heart Hospital at
Riverside Methodist Hospital, and director of nuclear imaging for Ohio Health
Heart and Vascular Physicians in Columbus, explains why the society did not
endorse the first-ever U.S. or international guideline for the evaluation and
diagnosis of patients with acute or stable chest pain.

Nuclear myocardial perfusion imaging (MPI) has been a gold-standard for
evaluation of coronary disease in patients for years, and it is included in the
new guidelines. However, computed tomography angiography (CTA) has seen immense
growth over the past decade and gained a prominent position in the guidelines as
a front line imaging modality. This is due to nearly all hospital emergency
rooms now having access to CT systems capable of performing immediate cardiac
exams. CT has been seen mainly as an anatomical imaging test, but it also can be
used for myocardial perfusion imaging using iodine contrast. While CT has had
limits with its ability to image through heavily calcified vessels or stents,
that is changing with new CT technologies now coming into service.

One new CT technology that is prominently included I the new chest pain
guidelines is CT fractional flow reserve (FFR-CT) imaging.  This uses a
computational fluid dynamics algorithm to analyze a patient's CTA. It sends back
a report and an interactive 3D reconstruction of all the coronary vessels that
shows a color coded drop in FFR ratios, which is a measure of blood flow. Past a
certain threshold, the reduced flow needs to be treated with revascularization.
Lower level blockages can be treated with drug therapies. FFR-CT is widely
expected in the coming years to become a gate keeper for invasive diagnostic
angiograms. The hope is it will eliminate the need for the majority of cath lab
angiogram exams and only send patients to the lab that need a stent or
angioplasty. 

However, the ASNC had major issues with FFR-CT being included in the chest pain
guidelines. Its board members argued there is need for more evidence and there
should have been more information contraindications for its use, which was
included on other imaging modalities in the guidelines. They also argued access
to the technology has been very limited. Calnon explains more detail in the
video on why this was a sticking point and caused the ASNC to not endorse the
guidelines.

Read more in the article — First International Chest Pain Diagnosis Guidelines
Released

Nuclear Imaging | February 01, 2022

VIDEO: Recent Advances in Cardiac Nuclear Imaging

American Society of Nuclear Cardiology (ASNC) President Dennis Calnon, M.D.,
MASNC, FASE, FSCCT, director of cardiac imaging for McConnell Heart Hospital at
Riverside Methodist Hospital, and director of nuclear imaging for Ohio Health
Heart and Vascular Physicians in Columbus, offers a concise overview of new
technologies that are enhancing cardiac nuclear imaging. He also explains some
of the new developments and uses for PET and SPECT imaging technology.

Find more nuclear imaging technology news

 

Artificial Intelligence | January 13, 2022

VIDEO: Examples of Artificial Intelligence PE Response Team Apps

Here are two examples of artificial intelligence (AI) driven pulmonary embolism
(PE) response team apps featured by vendors Aidoc and Viz.AI at the 2021
Radiological Society of North America (RSNA) 2021 meeting.

The AI scans computed tomography (CT) image datasets as they came off the
imaging system and looked for evidence of PE. If detected by the algorithm, it
immediately sends an alert to the stroke care team members via smartphone
messaging. This is done before the images are even loaded into the PACS. The
radiologist on the team can use a link on the app to open the CT dataset and has
basic tools for scrolling, windowing and leveling to determine if there is a PE
and the severity. The team can then use the app to send messages, access patient
information, imaging and reports. This enabled them all to be on the same
page and can communicate quickly via mobile devices, rather than being required
to use dedicated workstations in the hospital. 

Both vendors showed similar apps for stroke at RSNA 2019. That idea for rapid
alerts, diagnosis and communications for acute care teams has now expanded to PE
and also for aortic dissection and abdominal aortic aneurysms (AAA). AI.Viz and
Aidoc are looking at expanding this type of technology for other acute care team
rolls, including heart failure response. 

Read more about this technology in the article AI Can Facilitate Automated
Activation of Pulmonary Embolism Response Teams.

Find more AI news

Find more RSNA news and video

 

 

Coronavirus (COVID-19) | December 14, 2021

VIDEO: Study Reviews Severity of COVID-19 Heart Inflammation in College Athletes

Jean Jeudy, M.D., professor of radiology and vice chair of informatics at the
University of Maryland School of Medicine, presented a late-breaking study at
the 2021 Radiological Society of North America (RSNA) meeting on COVID-19 linked
myocarditis in college athletes. 

A small but significant percentage of college
athletes with COVID-19 develop myocarditis, a potentially dangerous inflammation
of the heart muscle, that can only be seen on cardiac MRI, according to the
study Jeudy presented. Myocarditis, which typically occurs as a result of a
bacterial or viral infection, can affect the heart’s rhythm and ability to pump
and often leaves behind lasting damage in the form of scarring to the heart
muscle. It has been linked to as many as 20% of sudden deaths in young athletes.
The COVID-19 pandemic raised concerns over an increased incidence of the
condition in student-athletes.

For the new study, clinicians at schools in the highly competitive Big Ten
athletic conference collaborated to collect data on the frequency of myocarditis
in student-athletes recovering from COVID-19 infection. Conference officials had
required all athletes who had COVID-19 to get a series of cardiac tests before
returning to play, providing a unique opportunity for researchers to collect
data on the athletes’ cardiac status.

Jeudy serves as the cardiac MRI core leader for the Big Ten Cardiac Registry.
This registry oversaw the collection of all the data from the individual schools
of the Big Ten conference. He reviewed the results of 1,597 cardiac MRI exams
collected at the 13 participating schools. 

Thirty-seven of the athletes, or 2.3%, were diagnosed with COVID-19 myocarditis,
a percentage on par with the incidence of myocarditis in the general population.
However, an alarmingly high proportion of the myocarditis cases were found in
athletes with no clinical symptoms. Twenty of the patients with COVID-19
myocarditis (54%) had neither cardiac symptoms nor cardiac testing
abnormalities. Only cardiac MRI identified the problem.

Read more details in the article COVID-19 Linked to Heart Inflammation in
College Athletes.


RELATED COVID-19 IMAGING AND MYOCARDITIS CONTENT:

Overview of Myocarditis Cases Caused by the COVID-19 Vaccine

COVID-19 Linked to Heart Inflammation in College Athletes — RSNA 2021
late-breaker

VIDEO: Cardiac MRI Assessment of Non-ischemic Myocardial Inflammation Caused by
COVID-19 Vaccinations — Interview with Kate Hanneman, M.D.

Cardiac MRI of Myocarditis After COVID-19 Vaccination in Adolescents

Large International Study Reveals Spectrum of COVID-19 Brain Complications -
RSNA 2021 late-breaker

COVID-19 During Pregnancy Doesn’t Harm Baby’s Brain

VIDEO: Large Radiology Study Reveals Spectrum of COVID-19 Brain Complications —
Interview with Scott Faro, M.D.

FDA Adds Myocarditis Warning to COVID mRNA Vaccine Clinician Fact Sheets

Small Number of Patients Have Myocarditis-like Illness After COVID-19
Vaccination


EP LAB VIEW ALL 82 ITEMS

Cardiac Imaging | February 01, 2022

VIDEO: Why the ASNC Did Not Endorse the 2021 Chest Pain Guidelines

American Society of Nuclear Cardiology (ASNC) President Dennis Calnon, M.D.,
MASNC, FASE, FSCCT, director of cardiac imaging for McConnell Heart Hospital at
Riverside Methodist Hospital, and director of nuclear imaging for Ohio Health
Heart and Vascular Physicians in Columbus, explains why the society did not
endorse the first-ever U.S. or international guideline for the evaluation and
diagnosis of patients with acute or stable chest pain.

Nuclear myocardial perfusion imaging (MPI) has been a gold-standard for
evaluation of coronary disease in patients for years, and it is included in the
new guidelines. However, computed tomography angiography (CTA) has seen immense
growth over the past decade and gained a prominent position in the guidelines as
a front line imaging modality. This is due to nearly all hospital emergency
rooms now having access to CT systems capable of performing immediate cardiac
exams. CT has been seen mainly as an anatomical imaging test, but it also can be
used for myocardial perfusion imaging using iodine contrast. While CT has had
limits with its ability to image through heavily calcified vessels or stents,
that is changing with new CT technologies now coming into service.

One new CT technology that is prominently included I the new chest pain
guidelines is CT fractional flow reserve (FFR-CT) imaging.  This uses a
computational fluid dynamics algorithm to analyze a patient's CTA. It sends back
a report and an interactive 3D reconstruction of all the coronary vessels that
shows a color coded drop in FFR ratios, which is a measure of blood flow. Past a
certain threshold, the reduced flow needs to be treated with revascularization.
Lower level blockages can be treated with drug therapies. FFR-CT is widely
expected in the coming years to become a gate keeper for invasive diagnostic
angiograms. The hope is it will eliminate the need for the majority of cath lab
angiogram exams and only send patients to the lab that need a stent or
angioplasty. 

However, the ASNC had major issues with FFR-CT being included in the chest pain
guidelines. Its board members argued there is need for more evidence and there
should have been more information contraindications for its use, which was
included on other imaging modalities in the guidelines. They also argued access
to the technology has been very limited. Calnon explains more detail in the
video on why this was a sticking point and caused the ASNC to not endorse the
guidelines.

Read more in the article — First International Chest Pain Diagnosis Guidelines
Released

Nuclear Imaging | February 01, 2022

VIDEO: Recent Advances in Cardiac Nuclear Imaging

American Society of Nuclear Cardiology (ASNC) President Dennis Calnon, M.D.,
MASNC, FASE, FSCCT, director of cardiac imaging for McConnell Heart Hospital at
Riverside Methodist Hospital, and director of nuclear imaging for Ohio Health
Heart and Vascular Physicians in Columbus, offers a concise overview of new
technologies that are enhancing cardiac nuclear imaging. He also explains some
of the new developments and uses for PET and SPECT imaging technology.

Find more nuclear imaging technology news

 

Artificial Intelligence | January 13, 2022

VIDEO: Examples of Artificial Intelligence PE Response Team Apps

Here are two examples of artificial intelligence (AI) driven pulmonary embolism
(PE) response team apps featured by vendors Aidoc and Viz.AI at the 2021
Radiological Society of North America (RSNA) 2021 meeting.

The AI scans computed tomography (CT) image datasets as they came off the
imaging system and looked for evidence of PE. If detected by the algorithm, it
immediately sends an alert to the stroke care team members via smartphone
messaging. This is done before the images are even loaded into the PACS. The
radiologist on the team can use a link on the app to open the CT dataset and has
basic tools for scrolling, windowing and leveling to determine if there is a PE
and the severity. The team can then use the app to send messages, access patient
information, imaging and reports. This enabled them all to be on the same
page and can communicate quickly via mobile devices, rather than being required
to use dedicated workstations in the hospital. 

Both vendors showed similar apps for stroke at RSNA 2019. That idea for rapid
alerts, diagnosis and communications for acute care teams has now expanded to PE
and also for aortic dissection and abdominal aortic aneurysms (AAA). AI.Viz and
Aidoc are looking at expanding this type of technology for other acute care team
rolls, including heart failure response. 

Read more about this technology in the article AI Can Facilitate Automated
Activation of Pulmonary Embolism Response Teams.

Find more AI news

Find more RSNA news and video

 

 

Coronavirus (COVID-19) | December 14, 2021

VIDEO: Study Reviews Severity of COVID-19 Heart Inflammation in College Athletes

Jean Jeudy, M.D., professor of radiology and vice chair of informatics at the
University of Maryland School of Medicine, presented a late-breaking study at
the 2021 Radiological Society of North America (RSNA) meeting on COVID-19 linked
myocarditis in college athletes. 

A small but significant percentage of college
athletes with COVID-19 develop myocarditis, a potentially dangerous inflammation
of the heart muscle, that can only be seen on cardiac MRI, according to the
study Jeudy presented. Myocarditis, which typically occurs as a result of a
bacterial or viral infection, can affect the heart’s rhythm and ability to pump
and often leaves behind lasting damage in the form of scarring to the heart
muscle. It has been linked to as many as 20% of sudden deaths in young athletes.
The COVID-19 pandemic raised concerns over an increased incidence of the
condition in student-athletes.

For the new study, clinicians at schools in the highly competitive Big Ten
athletic conference collaborated to collect data on the frequency of myocarditis
in student-athletes recovering from COVID-19 infection. Conference officials had
required all athletes who had COVID-19 to get a series of cardiac tests before
returning to play, providing a unique opportunity for researchers to collect
data on the athletes’ cardiac status.

Jeudy serves as the cardiac MRI core leader for the Big Ten Cardiac Registry.
This registry oversaw the collection of all the data from the individual schools
of the Big Ten conference. He reviewed the results of 1,597 cardiac MRI exams
collected at the 13 participating schools. 

Thirty-seven of the athletes, or 2.3%, were diagnosed with COVID-19 myocarditis,
a percentage on par with the incidence of myocarditis in the general population.
However, an alarmingly high proportion of the myocarditis cases were found in
athletes with no clinical symptoms. Twenty of the patients with COVID-19
myocarditis (54%) had neither cardiac symptoms nor cardiac testing
abnormalities. Only cardiac MRI identified the problem.

Read more details in the article COVID-19 Linked to Heart Inflammation in
College Athletes.


RELATED COVID-19 IMAGING AND MYOCARDITIS CONTENT:

Overview of Myocarditis Cases Caused by the COVID-19 Vaccine

COVID-19 Linked to Heart Inflammation in College Athletes — RSNA 2021
late-breaker

VIDEO: Cardiac MRI Assessment of Non-ischemic Myocardial Inflammation Caused by
COVID-19 Vaccinations — Interview with Kate Hanneman, M.D.

Cardiac MRI of Myocarditis After COVID-19 Vaccination in Adolescents

Large International Study Reveals Spectrum of COVID-19 Brain Complications -
RSNA 2021 late-breaker

COVID-19 During Pregnancy Doesn’t Harm Baby’s Brain

VIDEO: Large Radiology Study Reveals Spectrum of COVID-19 Brain Complications —
Interview with Scott Faro, M.D.

FDA Adds Myocarditis Warning to COVID mRNA Vaccine Clinician Fact Sheets

Small Number of Patients Have Myocarditis-like Illness After COVID-19
Vaccination


INFORMATION TECHNOLOGY VIEW ALL 167 ITEMS

Cardiac Imaging | February 01, 2022

VIDEO: Why the ASNC Did Not Endorse the 2021 Chest Pain Guidelines

American Society of Nuclear Cardiology (ASNC) President Dennis Calnon, M.D.,
MASNC, FASE, FSCCT, director of cardiac imaging for McConnell Heart Hospital at
Riverside Methodist Hospital, and director of nuclear imaging for Ohio Health
Heart and Vascular Physicians in Columbus, explains why the society did not
endorse the first-ever U.S. or international guideline for the evaluation and
diagnosis of patients with acute or stable chest pain.

Nuclear myocardial perfusion imaging (MPI) has been a gold-standard for
evaluation of coronary disease in patients for years, and it is included in the
new guidelines. However, computed tomography angiography (CTA) has seen immense
growth over the past decade and gained a prominent position in the guidelines as
a front line imaging modality. This is due to nearly all hospital emergency
rooms now having access to CT systems capable of performing immediate cardiac
exams. CT has been seen mainly as an anatomical imaging test, but it also can be
used for myocardial perfusion imaging using iodine contrast. While CT has had
limits with its ability to image through heavily calcified vessels or stents,
that is changing with new CT technologies now coming into service.

One new CT technology that is prominently included I the new chest pain
guidelines is CT fractional flow reserve (FFR-CT) imaging.  This uses a
computational fluid dynamics algorithm to analyze a patient's CTA. It sends back
a report and an interactive 3D reconstruction of all the coronary vessels that
shows a color coded drop in FFR ratios, which is a measure of blood flow. Past a
certain threshold, the reduced flow needs to be treated with revascularization.
Lower level blockages can be treated with drug therapies. FFR-CT is widely
expected in the coming years to become a gate keeper for invasive diagnostic
angiograms. The hope is it will eliminate the need for the majority of cath lab
angiogram exams and only send patients to the lab that need a stent or
angioplasty. 

However, the ASNC had major issues with FFR-CT being included in the chest pain
guidelines. Its board members argued there is need for more evidence and there
should have been more information contraindications for its use, which was
included on other imaging modalities in the guidelines. They also argued access
to the technology has been very limited. Calnon explains more detail in the
video on why this was a sticking point and caused the ASNC to not endorse the
guidelines.

Read more in the article — First International Chest Pain Diagnosis Guidelines
Released

Nuclear Imaging | February 01, 2022

VIDEO: Recent Advances in Cardiac Nuclear Imaging

American Society of Nuclear Cardiology (ASNC) President Dennis Calnon, M.D.,
MASNC, FASE, FSCCT, director of cardiac imaging for McConnell Heart Hospital at
Riverside Methodist Hospital, and director of nuclear imaging for Ohio Health
Heart and Vascular Physicians in Columbus, offers a concise overview of new
technologies that are enhancing cardiac nuclear imaging. He also explains some
of the new developments and uses for PET and SPECT imaging technology.

Find more nuclear imaging technology news

 

Artificial Intelligence | January 13, 2022

VIDEO: Examples of Artificial Intelligence PE Response Team Apps

Here are two examples of artificial intelligence (AI) driven pulmonary embolism
(PE) response team apps featured by vendors Aidoc and Viz.AI at the 2021
Radiological Society of North America (RSNA) 2021 meeting.

The AI scans computed tomography (CT) image datasets as they came off the
imaging system and looked for evidence of PE. If detected by the algorithm, it
immediately sends an alert to the stroke care team members via smartphone
messaging. This is done before the images are even loaded into the PACS. The
radiologist on the team can use a link on the app to open the CT dataset and has
basic tools for scrolling, windowing and leveling to determine if there is a PE
and the severity. The team can then use the app to send messages, access patient
information, imaging and reports. This enabled them all to be on the same
page and can communicate quickly via mobile devices, rather than being required
to use dedicated workstations in the hospital. 

Both vendors showed similar apps for stroke at RSNA 2019. That idea for rapid
alerts, diagnosis and communications for acute care teams has now expanded to PE
and also for aortic dissection and abdominal aortic aneurysms (AAA). AI.Viz and
Aidoc are looking at expanding this type of technology for other acute care team
rolls, including heart failure response. 

Read more about this technology in the article AI Can Facilitate Automated
Activation of Pulmonary Embolism Response Teams.

Find more AI news

Find more RSNA news and video

 

 

Coronavirus (COVID-19) | December 14, 2021

VIDEO: Study Reviews Severity of COVID-19 Heart Inflammation in College Athletes

Jean Jeudy, M.D., professor of radiology and vice chair of informatics at the
University of Maryland School of Medicine, presented a late-breaking study at
the 2021 Radiological Society of North America (RSNA) meeting on COVID-19 linked
myocarditis in college athletes. 

A small but significant percentage of college
athletes with COVID-19 develop myocarditis, a potentially dangerous inflammation
of the heart muscle, that can only be seen on cardiac MRI, according to the
study Jeudy presented. Myocarditis, which typically occurs as a result of a
bacterial or viral infection, can affect the heart’s rhythm and ability to pump
and often leaves behind lasting damage in the form of scarring to the heart
muscle. It has been linked to as many as 20% of sudden deaths in young athletes.
The COVID-19 pandemic raised concerns over an increased incidence of the
condition in student-athletes.

For the new study, clinicians at schools in the highly competitive Big Ten
athletic conference collaborated to collect data on the frequency of myocarditis
in student-athletes recovering from COVID-19 infection. Conference officials had
required all athletes who had COVID-19 to get a series of cardiac tests before
returning to play, providing a unique opportunity for researchers to collect
data on the athletes’ cardiac status.

Jeudy serves as the cardiac MRI core leader for the Big Ten Cardiac Registry.
This registry oversaw the collection of all the data from the individual schools
of the Big Ten conference. He reviewed the results of 1,597 cardiac MRI exams
collected at the 13 participating schools. 

Thirty-seven of the athletes, or 2.3%, were diagnosed with COVID-19 myocarditis,
a percentage on par with the incidence of myocarditis in the general population.
However, an alarmingly high proportion of the myocarditis cases were found in
athletes with no clinical symptoms. Twenty of the patients with COVID-19
myocarditis (54%) had neither cardiac symptoms nor cardiac testing
abnormalities. Only cardiac MRI identified the problem.

Read more details in the article COVID-19 Linked to Heart Inflammation in
College Athletes.


RELATED COVID-19 IMAGING AND MYOCARDITIS CONTENT:

Overview of Myocarditis Cases Caused by the COVID-19 Vaccine

COVID-19 Linked to Heart Inflammation in College Athletes — RSNA 2021
late-breaker

VIDEO: Cardiac MRI Assessment of Non-ischemic Myocardial Inflammation Caused by
COVID-19 Vaccinations — Interview with Kate Hanneman, M.D.

Cardiac MRI of Myocarditis After COVID-19 Vaccination in Adolescents

Large International Study Reveals Spectrum of COVID-19 Brain Complications -
RSNA 2021 late-breaker

COVID-19 During Pregnancy Doesn’t Harm Baby’s Brain

VIDEO: Large Radiology Study Reveals Spectrum of COVID-19 Brain Complications —
Interview with Scott Faro, M.D.

FDA Adds Myocarditis Warning to COVID mRNA Vaccine Clinician Fact Sheets

Small Number of Patients Have Myocarditis-like Illness After COVID-19
Vaccination




CURRENT ISSUE

January-February 2022

Subscribe to Magazine
Subscribe to Newsletters
Issue Archives
View Digital Edition




COMPARISON CHARTS



 * Drug-Coated Balloons
 * Septal Occluders
 * Echocardiology Reporting Systems
 * TEVAR Stent Grafts
 * 3-D Printing and Printing Services

See All Comparison Charts




Editorial Staff:
Editorial Director
 * Melinda Taschetta-Millane
 * melinda.taschetta-millane@wainscotmedia.com
 * P: 630-482-9932


BOTTOM MENU

 * Topics We Cover
 * Advertise
 * Contact
 * Privacy Policy
 * Cookie Policy
 * Terms and Conditions
 * Sitemap

© Copyright Wainscot Media. All Rights Reserved.


Subscribe Now
×

E-NEWSLETTER SUBSCRIPTION FORM


 * COVID-19
 * Imaging
    * Cardiac Ultrasound
    * Computed Tomography (CT)
    * Contrast Media
    * Magnetic Resonance Imaging (MRI)
    * Nuclear Imaging
    * Radiation Dose management

 * Cath Lab
    * Angiography systems
    * Balloon catheters
    * FFR Technologies
    * Hemostasis management
    * Hemodynamic Support
    * Hybrid OR
    * Intravascular imaging systems
    * Interventional radiology
    * Peripheral Artery Disease
    * Stents

 * EP Lab
    * Ablation systems
    * Atrial Fibrillation
    * Cardiac resynchronization therapy devices (CRT)
    * Implantable cardioverter defibrillators (ICD)
    * Leads, implantable devices
    * Pacemakers

 * Structural Heart
    * Congenital Heart
    * Heart Valve Technology
    * Hybrid OR
    * Left atrial appendage (LAA) occluders
    * Structural heart occluders/closure devices

 * Heart Failure
    * Stroke

 * Diagnostics
    * Blood Testing
    * ECG
    * Remote monitoring
    * Wearable Sensors

 * Pharma
 * Conference Coverage
    * ACC
    * AHA
    * AIMed
    * ASE
    * ASNC
    * EuroPCR
    * ESC
    * HIMSS
    * HRS
    * RSNA
    * SCAI
    * SCCT
    * TCT
    * VIVA

BY CONTINUING TO BROWSE OR BY CLICKING “ACCEPT” YOU AGREE TO THE STORING OF
COOKIES ON YOUR DEVICE TO ENHANCE YOUR SITE EXPERIENCE AND FOR ANALYTICAL AND
MARKETING PURPOSES.

To learn more about how we use cookies, please see our

cookie policy.
OK, I agree No, thanks
✓
Thanks for sharing!
AddToAny
More…